Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2006 1
2007 1
2010 1
2011 2
2012 7
2013 13
2014 9
2015 9
2016 9
2017 4
2018 6
2019 5
2020 2
2021 13
2022 11
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

82 results

Results by year

Filters applied: . Clear all
Page 1
Improved Screening of Monoclonal Gammopathy Patients by MALDI-TOF Mass Spectrometry.
Pečinka L, Vlachová M, Moráň L, Gregorová J, Porokh V, Kovačovicová P, Almáši M, Pour L, Štork M, Havel J, Ševčíková S, Vaňhara P. Pečinka L, et al. Among authors: sevcikova s. J Am Soc Mass Spectrom. 2023 Dec 6;34(12):2646-2653. doi: 10.1021/jasms.3c00166. Epub 2023 Nov 23. J Am Soc Mass Spectrom. 2023. PMID: 37994781 Free PMC article.
Daratumumab with lenalidomide and dexamethasone in relapsed or refractory multiple myeloma patients - real world evidence analysis.
Stork M, Spicka I, Radocha J, Minarik J, Jelinek T, Jungova A, Pavlicek P, Pospisilova L, Sedlak F, Straub J, Pika T, Knechtova Z, Fidrichova A, Boichuk I, Sevcikova S, Maisnar V, Hajek R, Pour L. Stork M, et al. Among authors: sevcikova s. Ann Hematol. 2023 Jun;102(6):1501-1511. doi: 10.1007/s00277-023-05188-4. Epub 2023 Apr 24. Ann Hematol. 2023. PMID: 37088816 Free PMC article.
Real-world evidence of efficacy and safety of pomalidomide and dexamethasone in relapsed/refractory multiple myeloma patients: Czech registry data.
Sandecka V, Pour L, Špička I, Minařík J, Radocha J, Jelínek T, Pavlíček P, Jungová A, Kessler P, Wróbel M, Štork M, Štraub J, Pika T, Čápková L, Ševčíková S, Maisnar V, Hájek R. Sandecka V, et al. Among authors: sevcikova s. Neoplasma. 2022 Dec;69(6):1474-1479. doi: 10.4149/neo_2022_220813N827. Neoplasma. 2022. PMID: 36591805
Involvement of Small Non-Coding RNA and Cell Antigens in Pathogenesis of Extramedullary Multiple Myeloma.
Vlachová M, Gregorová J, Vychytilová-Faltejsková P, Gabło NA, Radová L, Pospíšilová L, Almáši M, Štork M, Knechtová Z, Minařík J, Popková T, Jelínek T, Hájek R, Pour L, Říhová L, Ševčíková S. Vlachová M, et al. Among authors: sevcikova s. Int J Mol Sci. 2022 Nov 25;23(23):14765. doi: 10.3390/ijms232314765. Int J Mol Sci. 2022. PMID: 36499093 Free PMC article.
Immunomodulatory Agents for Multiple Myeloma.
Minařík J, Ševčíková S. Minařík J, et al. Among authors: sevcikova s. Cancers (Basel). 2022 Nov 23;14(23):5759. doi: 10.3390/cancers14235759. Cancers (Basel). 2022. PMID: 36497241 Free PMC article.
More Than 2% of Circulating Tumor Plasma Cells Defines Plasma Cell Leukemia-Like Multiple Myeloma.
Jelinek T, Bezdekova R, Zihala D, Sevcikova T, Anilkumar Sithara A, Pospisilova L, Sevcikova S, Polackova P, Stork M, Knechtova Z, Venglar O, Kapustova V, Popkova T, Muronova L, Chyra Z, Hrdinka M, Simicek M, Garcés JJ, Puig N, Cedena MT, Jurczyszyn A, Castillo JJ, Penka M, Radocha J, Mateos MV, San-Miguel JF, Paiva B, Pour L, Rihova L, Hajek R. Jelinek T, et al. Among authors: sevcikova s. J Clin Oncol. 2023 Mar 1;41(7):1383-1392. doi: 10.1200/JCO.22.01226. Epub 2022 Oct 31. J Clin Oncol. 2023. PMID: 36315921 Free PMC article.
Unexpected Heterogeneity of Newly Diagnosed Multiple Myeloma Patients with Plasmacytomas.
Stork M, Sevcikova S, Jelinek T, Minarik J, Radocha J, Pika T, Pospisilova L, Spicka I, Straub J, Pavlicek P, Jungova A, Knechtova Z, Sandecka V, Maisnar V, Hajek R, Pour L. Stork M, et al. Among authors: sevcikova s. Biomedicines. 2022 Oct 11;10(10):2535. doi: 10.3390/biomedicines10102535. Biomedicines. 2022. PMID: 36289797 Free PMC article.
IgG4-related disease. Clinical manifestation differential diagnosis and recent International Diagnostic Criteria for IgG4-related disease.
Adam Z, Zeman D, Čermák A, Dastych M, Doubková M, Horváth T, Skorkovská Š, Adamová Z, Řehák Z, Koukalová R, Pour L, Štork M, Krejčí M, Sandecká V, Ševčíková S, Král Z. Adam Z, et al. Among authors: sevcikova s. Vnitr Lek. 2022 Fall;68(E-5):4-19. doi: 10.36290/vnl.2022.070. Vnitr Lek. 2022. PMID: 36283812 Review. English.
Multicentric Castlemans disease. Symptoms, diagnostics and therapy.
Adam Z, Řehák Z, Adamová Z, Koukalová R, Pour L, Krejčí M, Boichuk I, Sandecká V, Krejčí M, Štork M, Ševčíková S, Král Z. Adam Z, et al. Among authors: sevcikova s. Vnitr Lek. 2022 Winter;68(1):41-53. Vnitr Lek. 2022. PMID: 35459346 English.
82 results